Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Mochida Pharmaceutical Company, Ltd.
With
Pfizer
Age
20–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient with diagnosis of Major Depressive Disorder (MDD) based on the criteria in the Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5).
Hamilton Depression Rating Scale-17 (HAM-D17) total score of ≥20.
You may not be if
Patient who meets DSM-5 criteria of the following disorders for current or past history.
Schizophrenia spectrum and other psychotic disorders Bipolar and related disorders Substance use disorders (exclusive of tobacco and caffeine)
Patient who had suicidal behavior in Columbia-Suicide Severity Rating Scale (C-SSRS) within 1 year before start of screening phase.
Clareo Health | A Study of MD-120 in Patients With Depression
